LILACS – Literatura Latinoamericana y del Caribe de Ciencias de la Salud

Possible therapeutics for Pseudomyxoma peritonei: a rare, lethal, and the least investigated disease

Nazmeen, Aarifa.

J. coloproctol. (Rio J., Impr.); 43 (2), 2023

Pseudomyxoma peritonei (PMP) refers to a growth disorder characterized by glycoprotein neoplasm in the peritoneum, where mucin oversecretion occurs. The tumors of the appendix region are well associated with PMP; however, ovarian, colon, stomach, pancreas, and urachus tumors have also been linked to PMP....

Seudomixoma Peritoneal/tratamiento farmacológico, Aporfinas/uso terapéutico, Amilorida/uso terapéutico, Dexametasona/uso terapéutico, Naltrexona/uso terapéutico, Retinoides/uso terapéutico, Metilación/efectos de los fármacos, Mucinas/efectos de los fármacos, Calcio

Fulltext

Pseudomyxoma peritonei originating from appendix tumors

ABSTRACT Background: Appendix tumors represent about 1% of all gastrointestinal neoplasia, in other words they are quite rare. However, there is a specific type of appendiceal neoplasms (mucinous adenocarcinoma) that spreads to the peritoneum and in almost 20% of the cases, resulting in a disease called...